CLOPIDOGREL VS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS

这是一项三盲随机研究，分为两组： 氯吡格雷每日75毫克，阿司匹林325毫克。这项研究将让人们 在随机化后的六个月内中风的人，并将跟随 以评估氯吡格雷与氯吡格雷的相对疗效 阿司匹林降低脑缺血综合结局的发生率 中风，以及这两种药物的相对安全性和耐受性。

This is a triple-blind, randomized study with two parallel groups: Clopidogrel 75 mg daily vs aspirin 325 mg. The study will take people who have had strokes within six months of randomization and will follow them for three years to assess the relative efficacy of Clopidogrel vs aspirin in reducing the incidence of the composite outcome of ischemic stroke, as well as the relative safety and tolerability of the two drugs.